BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36603549)

  • 21. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
    de Haas TG; Kool M
    Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
    Zindy F; Uziel T; Ayrault O; Calabrese C; Valentine M; Rehg JE; Gilbertson RJ; Sherr CJ; Roussel MF
    Cancer Res; 2007 Mar; 67(6):2676-84. PubMed ID: 17363588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA polymerase β deficiency in the p53 null cerebellum leads to medulloblastoma formation.
    Kim J; Kim J; Lee Y
    Biochem Biophys Res Commun; 2018 Oct; 505(2):548-553. PubMed ID: 30274781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation.
    Anne SL; Govek EE; Ayrault O; Kim JH; Zhu X; Murphy DA; Van Aelst L; Roussel MF; Hatten ME
    PLoS One; 2013; 8(11):e81769. PubMed ID: 24303070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Cilia in the Murine Cerebellum and in Mutant Models of Medulloblastoma.
    Di Pietro C; Marazziti D; La Sala G; Abbaszadeh Z; Golini E; Matteoni R; Tocchini-Valentini GP
    Cell Mol Neurobiol; 2017 Jan; 37(1):145-154. PubMed ID: 26935062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.
    Bhatia S; Baig NA; Timofeeva O; Pasquale EB; Hirsch K; MacDonald TJ; Dritschilo A; Lee YC; Henkemeyer M; Rood B; Jung M; Wang XJ; Kool M; Rodriguez O; Albanese C; Karam SD
    Oncotarget; 2015 Apr; 6(11):8929-46. PubMed ID: 25879388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.
    Knight ER; Patel EY; Flowers CA; Crowther AJ; Ting JP; Miller CR; Gershon TR; Deshmukh M
    Oncogene; 2015 Jan; 34(3):394-402. PubMed ID: 24469054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medulloblastoma in newborn sisters. Report of two cases.
    Belamaric J; Chau AS
    J Neurosurg; 1969 Jan; 30(1):76-9. PubMed ID: 5766622
    [No Abstract]   [Full Text] [Related]  

  • 30. Medulloblastoma: a potpourri of distinct entities.
    Pfister S
    Acta Neuropathol; 2012 Apr; 123(4):463-4. PubMed ID: 22392443
    [No Abstract]   [Full Text] [Related]  

  • 31. Mini-symposium in medulloblastoma genomics in the modern molecular era.
    Ellison DW
    Brain Pathol; 2020 May; 30(3):661-663. PubMed ID: 32243002
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined p53 and MYC Alterations Are Common in Relapsed Medulloblastoma.
    Cancer Discov; 2015 Feb; 5(2):OF7. PubMed ID: 25656905
    [No Abstract]   [Full Text] [Related]  

  • 33. Medulloblastoma stem cells: modeling tumor heterogeneity.
    Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
    Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
    Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM
    Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastoma: molecular genetics and animal models.
    Raffel C
    Neoplasia; 2004; 6(4):310-22. PubMed ID: 15256053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mouse model of the most aggressive subgroup of human medulloblastoma.
    Kawauchi D; Robinson G; Uziel T; Gibson P; Rehg J; Gao C; Finkelstein D; Qu C; Pounds S; Ellison DW; Gilbertson RJ; Roussel MF
    Cancer Cell; 2012 Feb; 21(2):168-80. PubMed ID: 22340591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medulloblastoma in two brothers.
    Yamashita Y; Handa H; Toyama M
    Surg Neurol; 1975 Aug; 4(2):225-7. PubMed ID: 1162594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
    Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
    Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
    Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
    Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tis21 knock-out enhances the frequency of medulloblastoma in Patched1 heterozygous mice by inhibiting the Cxcl3-dependent migration of cerebellar neurons.
    Farioli-Vecchioli S; Cinà I; Ceccarelli M; Micheli L; Leonardi L; Ciotti MT; De Bardi M; Di Rocco C; Pallini R; Cavallaro S; Tirone F
    J Neurosci; 2012 Oct; 32(44):15547-64. PubMed ID: 23115191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.